EVALUASI POLA TERAPI PENGOBATAN PENYAKIT-PENYAKIT PENYERTA (KOMORBID) PADA PASIEN HIV/AIDS DI RUANG RAWAT INAP RUMAH SAKIT UMUM IMELDA PEKERJA INDONESIA MEDAN
Abstract
Comorbid diseases can be found in HIV/AIDS pateients. Comorbid are comorbid diseases that are not related to the diagnosis of the main disease or the patients condition. The purpose of this study was todetermine the pattern of therapy comorbid diseases (comorbid) in HIV/AIDS patients in the inpatient room at Rumah Sakit Umum Imelda Pekerja Indonesia Medan. The sample of this study amounted to 34 people. This type of research is a descriptive observation study where the date are taken retrospectively and analyzed by descriptive statistical methods. The result showed that majority of patients in Rumah Sakit Umum Imelda Pekerja Indonesia Medan is men as many 27 people (79,4%). The most common comorbid diseases foun in HIV/AIDS patients is hyponatremiaas many 20 people (25%), hypokalemia as many 12 people (15%), and dyspepsia as many as 9 people (11,25%). The most common comorbid treatment patterns given to HIV/AIDS patients are antibiotic abd analgesic. Where the antibiotic is ceftriaxone (52.9%) and the analgesic is ketorolac (61.8%), In addition, there is the provision of diarrhea medicine using Diaform (55.9%), Stomach medicine using Antacids (52.9%), suplements using Channa (44,1%) and sedatives using Alprazolam (52.9%). In addition to treatment therapy, HIV/AIDS patients also recived blood transfusion as many as 5 people.
References
Baroroh, F., & Sari, A. (2017). Analisis Efektivitas Biaya Pengobatan Kombinasi Candesartan-Amlodipin Dibandingkan Dengan Kombinasi Candesartan-Diltiazem Pada Pasien Hipertensi Rawat Jalan. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 14(2). http://jurnalnasional.ump.ac.id/index.php/PHARMACY/article/view/1952
Dewi, M. I. K., Prabowo, W. C., & Rusli, R. (2019). Analisis Biaya Minimal Penggunaan Antihipertensi Di Rumah Sakit Umum Daerah Kota Bontang. Proceeding of Mulawarman Pharmaceuticals Conferences, 9. https://prosiding.farmasi.unmul.ac.id/index.php/mpc/article/view/338
Hasan D, Metode Analisis Dalam Ekonomi Kesehatan, Materi Kuliah Farmakoekonomi, Magister Farmasi Univesitas Pancasila, Jakarta, 2012 Hal 1-6
Hariawan, H., & Tatisina, C. M. (2020). Pelaksanaan Pemberdayaan Keluarga Dan Senam Hipertensi Sebagai Upaya Manajemen Diri Penderita Hipertensi. Jurnal Pengabdian Masyarakat Sasambo, 1(2). https://doi.org/http://dx.doi.org/10.32807/jpms.v1i2.478
Hutagalung, S. (2019). Gambaran Penggunaan Resep Obat Antihipertensi Pasien Rawat Inap di RSUD. Dr. Pirngadi Kota Medan.
Mayangsari, E., Lestari, B., & Nurdiana. (2019). Farmakoterapi Kardiovaskuler. Malang: UB Press.
Riset Kesehatan Dasar (Riskesdas). (2018). Badan Penelitian dan Pengembangan Kesehatan Kementerian RI tahun 2018.
Sartik, Tjekyan, R. S., & M.Zulkarnain. (2017). Faktor – Faktor Risiko dan Angka Kejadian Hipertensi pada Penduduk Palembang. Jurnal Ilmu Kesehatan Masyarakat (JIKM, 8(3). https://doi.org/M.Zulkarnain
Vogenberg, F.R., 2001, Introduction to Pharmacoeconomics, McGraw-Hill Companies, Hal. 127-143, USA.
Wijayanti, N. Wi., Makaddas, A., & Tandah, M. R. (2016). Analisis Efektifitas Biaya Pengobatan Kombinasi Amlodipin Furosemid dibandingkan dengan Kombinasi Amlodipin Bisoprolol pada Pasien Hipertensi Rawat Jalan di RSUD Undata Palu Periode Agustus-Oktober Tahun 2014. Natural Science: Jurnal Science and Technology, 5(1). http://jurnal.untad.ac.id/jurnal/index.php/ejurnalfmipa/article/view/5556